A threshold cost-effectiveness comparison of infliximab and etanercept in adults with rheumatoid arthritis in the UK.

被引：0
|
作者：
Bansback, N
Brennan, A
Conway, P
Reynolds, AV
机构：
[1] Sch Hlth & Related Res, Sheffield, S Yorkshire, England
[2] Wyeth, Maidenhead, Berks, England
来源：
ARTHRITIS AND RHEUMATISM | 2002年 / 46卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S582 / S582
页数：1
相关论文
共 50 条
  • [1] Modelling the cost-effectiveness of etanercept in adults with rheumatoid arthritis (RA) in the UK.
    Brennan, A
    Bansback, N
    Conway, P
    Reynolds, AV
    [J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S157 - S157
  • [2] MODELLING THE COST-EFFECTIVENESS OF ETANERCEPT IN ADULTS WITH RHEUMATOID ARTHRITIS IN THE UK
    Brennan, A.
    Bansback, N.
    Conway, P.
    Reynolds, A.
    [J]. RHEUMATOLOGY, 2002, 41 : 91 - 91
  • [3] Modelling the cost-effectiveness of etanercept in adults with rheumatoid arthritis in the UK
    Brennan, A
    Bansback, N
    Reynolds, A
    Conway, P
    [J]. RHEUMATOLOGY, 2004, 43 (01) : 62 - 72
  • [4] A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness
    Chen, Y-F
    Jobanputra, P.
    Barton, P.
    Jowett, S.
    Bryan, S.
    Clark, W.
    Fry-Smith, A.
    Burls, A.
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2006, 10 (42) : 1 - +
  • [5] COST-EFFECTIVENESS ANALYSIS OF ETANERCEPT AND INFLIXIMAB IN THE TREATMENT OF RHEUMATOID ARTHRITIS (RA) IN SPAIN
    Guijarro, P.
    Crespo, C.
    Brosa, M.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A448 - A448
  • [6] Cost-Effectiveness Analysis of Biopharmaceuticals for Treating Rheumatoid Arthritis: Infliximab, Adalimumab, and Etanercept
    Gholami, Ahmad
    Azizpoor, Jassem
    Aflaki, Elham
    Rezaee, Mehdi
    Keshavarz, Khosro
    [J]. BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [7] Cost-effectiveness analysis of etanercept vs infliximab for treatment of severe rheumatoid arthritis in Brazil
    Saggia, M. G.
    Pina, F. P.
    [J]. VALUE IN HEALTH, 2006, 9 (06) : A220 - A220
  • [8] Cost-effectiveness of infliximab for rheumatoid arthritis in Spain
    Wong, JB
    Ballina, J
    Fernandez-Sueiro, J
    Garcia-Vadillo, J
    Gonzalez-Fernandez, C
    Gonzalez-Crespo, M
    Gratacos, J
    Ivorra, J
    Navarro-Sarabia, F
    Tornero, J
    Casado, MA
    Fosbrook, L
    Pocovi, A
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 520 - 521
  • [9] The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis
    Vergel, Y. Bravo
    Hawkins, N. S.
    Claxton, K.
    Asseburg, C.
    Palmer, S.
    Woolacott, N.
    Bruce, I. N.
    Sculpher, M. J.
    [J]. RHEUMATOLOGY, 2007, 46 (11) : 1729 - 1735
  • [10] Cost-effectiveness analysis of etanercept versus infliximab and anakinra in the treatment of rheumatoid arthritis in italy.
    Leardini, G
    Ganguly, R
    Singh, A
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S460 - S461
12345